These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 2905936
1. Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure. Hachisu T, Yokoyama T, Oda Y, Ando K, Hattori Y, Yoshida T. Clin Ther; 1988; 10(6):656-63. PubMed ID: 2905936 [Abstract] [Full Text] [Related]
2. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study. Morgan MY, Stambuk D. Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149 [Abstract] [Full Text] [Related]
3. Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man. Lin JH, Chremos AN, Yeh KC, Antonello J, Hessey GA. Eur J Clin Pharmacol; 1988; 34(1):41-6. PubMed ID: 2896129 [Abstract] [Full Text] [Related]
4. [Famotidine treatment of patients with gastric and duodenal ulcers. A comparative study with once or twice-a-day administration]. Bonardelli P, Fujita Y, Fujita R, Sugata F. Clin Ter; 1987 Aug 15; 122(3):183-7. PubMed ID: 2904317 [No Abstract] [Full Text] [Related]
5. Pharmacokinetics of famotidine in man. Kroemer H, Klotz U. Int J Clin Pharmacol Ther Toxicol; 1987 Aug 15; 25(8):458-63. PubMed ID: 2888738 [Abstract] [Full Text] [Related]
6. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis. Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE. Clin Pharmacol Ther; 1996 Nov 15; 60(5):535-42. PubMed ID: 8941026 [Abstract] [Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
14. Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects. Eley T, Luo FR, Agrawal S, Sanil A, Manning J, Li T, Blackwood-Chirchir A, Bertz R. J Clin Pharmacol; 2009 Jun 15; 49(6):700-9. PubMed ID: 19395585 [Abstract] [Full Text] [Related]
19. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease. Kedziora-Kornatowska K, Tkaczewski W, Blaszczyk J, Buczynski A, Chojnacki J, Kedziora J. Hepatogastroenterology; 1998 Jun 15; 45(19):276-80. PubMed ID: 9496526 [Abstract] [Full Text] [Related]